Kit Check

Diversion Trends 2022 Report Out Now!

Fully distributed

There is no central office. All members of the team work remotely.

💼Healthcare

👥51-200

📍Washington, DC

Kit Check

About Kit Check

KitCheck is a provider of a cloud software platform used to offer automated hospital pharmacy kit processing and medication tracking.

What Kit Check is building

Our groundbreaking Medication Intelligence™ solutions provide item-level visibility, workflow simplicity, and actionable analytics, empowering stakeholders to deliver the right medicine to the right patient at the right time, every time. To date, our more than 950 U.S. and Canadian hospital partners have adopted Kit Check solutions to solve the most challenging of healthcare problems.

Technologies used at Kit Check

Back-end (4)

Front-end (2)

Python

AWS

MySQL

Company culture

Get Stuff Done

We take ownership and action to change the industry and ourselves. We identify root causes, engage with the real problem, hit our deadlines, and follow through until the job is done.

Join Forces

We work together to solve problems that are beyond the domain of any individual, and we support each other to ensure we are doing the right things for our customers, the company, and the team. We fight for our ideas without making it personal, and own decisions and outcomes together.

Funding rounds

Total Funding

$49.9M

Last funding round type

Debt Financing

Company type

For Profit

Kit Check news and updates

KitCheck, Inc. launches Bluesight for Controlled Substances’ rebrand to ControlCheck

It’s with great pleasure that KitCheck, Inc. announce Bluesight for Controlled Substances’ rebrand to ControlCheck.

Dec 13, 2022 | bluesight.com

KitCheck, Inc. launches Insights Quarterly

Kit Check just launched its Insights Quarterly.

Sep 21, 2022 | kitcheck.com

KitCheck, Inc. launched Radio Frequency Identification on Aug 31st 22'.

Kit Check, the leading automation vendor in Medication Intelligence™, today announced that its proprietary Radio Frequency Identification (RFID) technology will be incorporated in the new KinetiX™ Propofol syringes being developed by Genixus™, a pharmaceutical company and FDA-registered repackager and 503B outsourcing provider focused on transforming acute and critical care medicines.

Aug 31, 2022 | kitcheck.com

KitCheck, Inc. hired Erica Tingley as Chief Financial Officer on Mar 3rd 22'.

Kit Check, the leader in Medication Intelligence™ solutions that bring cost savings, efficiency, and patient safety to hospitals, today announced the addition of Erica Tingley as Chief Financial Officer.

Jan 1, 2022 | streetinsider.com

KitCheck, Inc. launched findings of eighth annual Hospital Pharmacy Operations Report on Mar 24th 22'.

ALEXANDRIA (March, 24) –Kit Check, the leading automation vendor in Medication Intelligence™ solutions that bring cost savings, efficiency, and patient safety to hospitals, today released the findings of its eighth annual Hospital Pharmacy Operations Report (HPOR), which surveyed 118 hospital pharmacy professionals in the fourth quarter of 2021.

Jan 1, 2022 | kitcheck.com

KitCheck, Inc. launches Diversion Trends Report

Kit Check, the industry leader in Medication Intelligence™ solutions for hospitals, today announced the findings of its first-ever Diversion Trends Report, which analyzed controlled substance medication transactions in more than 230 hospitals using Bluesight™ for Controlled Substances between September 2018 and December 2021.

Jan 1, 2022 | businesswire.com

KitCheck, Inc. partnered with Fagron on May 9th 22'.

Recently, Kit Check announced its partnership with Fagron in launching RFID tagged, ready-to use, OR syringes.

Jan 1, 2022 | kitcheck.com

KitCheck, Inc. recognized as Best in KLAS on Jun 22nd 22'.

Earlier this year, Kit Check was ranked Best in KLAS for drug diversion monitoring for the third consecutive year.

Jan 1, 2022 | kitcheck.com